80
Participants
Start Date
May 29, 2018
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2025
Nivolumab
"FLOX: Intravenous oxaliplatin 85 mg/m2 on day 1; bolus 5-fluorouracil 500 mg/m2 and bolus Leucovorin on days 1 and 2; IV administration every 2 weeks.~Nivolumab: 240 mg flat dose; IV administration every 2 weeks."
FLOX
FLOX: Intravenous oxaliplatin 85 mg/m2 on day 1; bolus 5-fluorouracil 500 mg/m2 and bolus Leucovorin on days 1 and 2; IV administration every 2 weeks.
Akershus University Hospital, Oslo
Hospital of Southern Norway, Department of Oncology, Kristiansand
Haukeland University Hospital, Bergen
St Olav's Hospital - Trondheim University Hospital, Trondheim
Oslo University Hospital, Oslo
Trondheim University Hospital
OTHER
Haukeland University Hospital
OTHER
Hospital of Southern Norway Trust
OTHER
Oslo University Hospital
OTHER
University Hospital, Akershus
OTHER